These findings reveal the role of the CXCL10/CXCR3/NF-κB signaling pathway in breast cancer progression, providing a potential target for new therapeutic strategies (Kim et al., 2018; Jin et al., 2017). This evidence concerns the gene CXCL10 and breast cancer.